Steven L Warner

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Endoplasmic Reticulum Stress

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Molecular cancer therapeutics

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, Elizabeth L Siegler, Sutapa Sinha, Michael J Hansen, Carli M Stewart, Jennifer M Feigin, Claudia Manriquez Roman, Kendall J Schick, Ismail Can, Erin E Tapper, Paulina Horvei, Mohamad M Adada, Evandro D Bezerra, Lionel Aurelien A Kankeu Fonkoua, Michael W Ruff, Cynthia L Forsman, Wendy K Nevala, Justin C Boysen, Renee C Tschumper, Cory L Grand, Kamesh R Kuchimanchi, Lars Mouritsen, Jason M Foulks, Steven L Warner, Timothy G Call, Sameer A Parikh, Wei Ding, Neil E Kay, Saad Sirop Kenderian
AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells. Cancer immunology research (2023)
Yuqing Zhang, Emily N Arner, Ali Rizvi, Jason E Toombs, Huocong Huang, Steven L Warner, Jason M Foulks, Rolf A Brekken
AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer. Molecular cancer therapeutics (2021)